Betablocker use associated with reduced mortality in HFrEF patients >80 years
In the Cardiovascular Scene Investigation (CSI) series, investigators from Utrecht report at the ESC congress, from the perspective of young investigators. They put a question to researchers about presented study results.
Gianluigi Savarese, MD - Cardiologist and researcher, Karolinska Institute, Sweden
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.